Cargando…

The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy

SIMPLE SUMMARY: Despite remarkable progress being made by preventive medical check-ups in the last decades, colorectal cancer (CRC) remains one of the most frequent and deadliest cancers worldwide. An understanding of the mutational landscape in CRC is needed to develop new mutanome-directed therapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Michel, Maurice, Kaps, Leonard, Maderer, Annett, Galle, Peter R., Moehler, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150459/ https://www.ncbi.nlm.nih.gov/pubmed/34064974 http://dx.doi.org/10.3390/cancers13102296

Ejemplares similares

Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft—no benefit of combination therapy
por: Wehler, Thomas C., et al.
Publicado: (2012)

Loss of LLGL1 Expression Correlates with Diffuse Gastric Cancer and Distant Peritoneal Metastases
por: Desuki, Alexander, et al.
Publicado: (2019)

Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program
por: Moehler, Markus, et al.
Publicado: (2019)

Comparative analysis of nuclear and mitochondrial DNA from tissue and liquid biopsies of colorectal cancer patients
por: Haupts, Anna, et al.
Publicado: (2021)

VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
por: Thomaidis, Thomas, et al.
Publicado: (2014)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Proteins of the VEGFR and EGFR pathway as predictive markers for adjuvant treatment in patients with stage II/III colorectal cancer: results of the FOGT-4 trial
por: Thomaidis, Thomas, et al.
Publicado: (2014)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Influence of the oncolytic parvovirus H-1, CTLA-4 antibody tremelimumab and cytostatic drugs on the human immune system in a human in vitro model of colorectal cancer cells
por: Heinrich, Bernd, et al.
Publicado: (2013)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

The Role of p53 Signaling in Colorectal Cancer
por: Liebl, Magdalena C., et al.
Publicado: (2021)

Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
por: Moore, Assaf, et al.
Publicado: (2020)

Docetaxel as Salvage Therapy in Highly Pretreated and Drug Resistant Gastrointestinal Carcinomas
por: Sprinzl, Martin F., et al.
Publicado: (2008)

Overexpression of p53 mRNA in colorectal cancer and its relationship to p53 gene mutation.
por: el-Mahdani, N., et al.
Publicado: (1997)

Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer
por: Teufel, Andreas, et al.
Publicado: (2004)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Role of p53 in breast cancer progression: An insight into p53 targeted therapy
por: Marvalim, Charlie, et al.
Publicado: (2023)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy
por: Murray, David, et al.
Publicado: (2020)

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression
por: Han, Yang, et al.
Publicado: (2023)

Expression of Cyclooxygenase-2 and its Relationship to p53 Accumulation in Colorectal Cancers
por: Lim, Sung-Chul, et al.
Publicado: (2007)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

The role of MDM2–p53 axis dysfunction in the hepatocellular carcinoma transformation
por: Cao, Hui, et al.
Publicado: (2020)

Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
por: Wang, Yidian, et al.
Publicado: (2023)

P53 in lung vascular barrier dysfunction
por: Barabutis, Nektarios
Publicado: (2020)

p53 Isoforms and Their Implications in Cancer
por: Vieler, Maximilian, et al.
Publicado: (2018)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53
por: Wang, Wei-Lin, et al.
Publicado: (2022)

p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance.
por: Yamaguchi, A., et al.
Publicado: (1993)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

Role of Liver-Mediated Tolerance in Nanoparticle-Based Tumor Therapy
por: Cacicedo, Maximiliano L., et al.
Publicado: (2020)

p53 Function and Dysfunction in Human Health and Diseases
por: D’Orazi, Gabriella
Publicado: (2023)

Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
por: Moehler, Markus, et al.
Publicado: (2016)

Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)
por: Rades, Dirk, et al.
Publicado: (2020)

The p53 family orchestrates the regulation of metabolism: physiological regulation and implications for cancer therapy
por: Napoli, Marco, et al.
Publicado: (2017)

p53 Mutations and DNA Ploidy in Colorectal Adenocarcinomas
por: Campomenosi, Paola, et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_ious17qph4e8dhmdobv8gc66f7